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127 Characterization of bacteria isolated from the respiratory tract
of pediatric cystic ﬁbrosis patients followed in a CF specialized
center
P. Roma˜o1, R. Jotta1, R. Sousa1, L. Pereira1, C. Barreto1. 1Hospital de Santa
Maria, CHLN, Specialized Center of Cystic Fibrosis, Lisbon, Portugal
Objectives: Respiratory infections occur early in life of patients with Cystic
Fibrosis (CF). Bacterial respiratory colonization has been associated with increased
morbidity and mortality in these patients. This study aims to evaluate the prevalence
of bacteria isolated from the respiratory tract in patients followed at a Specialized
Center of CF (Lisbon) in the last 5 years.
Methods: Retrospective analysis of patients followed in the CF Center, between
2008 and 2012. Epidemiological and bacteriological data were evaluated.
Conclusion: Sixty four patients (34 females) were evaluated with a median age
of 11 years. MSSA was the most frequently isolated bacteria during the ﬁve years
of the study, followed by PA. In general, 2012 was the year with lower prevalence
of chronic colonization by pathogenic bacteria. The exceptions were two bacteria
of uncertain clinical signiﬁcance (SM and AX) (see table). Segregation of patients
by colonization was strictly followed. The rate of patients taking inhaled AB was
maintained over the time.
Bacterial Isolation/Chronic colonization (%)
2008 2009 2010 2011 2012
Pseudomonas aeruginosa (PA) 45.3/26.4 47.3/27.3 56.9/24.1 57.1/19.6 40.4/12.3
Burkholderia cepacia complex (BC) 13.2/7.5 9/1.8 12/6.9 14.3/7.1 8.8/5.3
Staphylococcus aureus
Methicillin-sensitive (MSSA) 69.8/34 70.9/34.5 70.7/44.8 66/44.6 68.4/31.6
Methicillin-resistant (MRSA) 13.2/5.7 16.3/5.5 19/8.6 10.7/7.1 10.5/5.3
Stenotrophomonas maltophilia (SM) 5.7/0 9/0 10.3/0 7.1/1.8 7/3.5
Achromobacter xylosoxidans (AX) 1.9/0 1.8/0 3.4/1.7 3.6/1.8 14/3.5
In conclusion, the prevalence of bacterial colonization varies over the years. The
results reinforce the importance of the transmission control measures according to
the type of bacterial colonization.
128 Differences in lower airway infection rates between AREST CF
study centres
E. Hart1,2, S.C. Ranganathan1,2,3, Australian Respiratory Early Surveillance
Team for Cystic Fibrosis (AREST CF). 1Murdoch Childrens Research Institute,
Respiratory Medicine, Melbourne, Australia; 2Royal Children’s Hospital,
Respiratory Medicine, Melbourne, Australia; 3The University of Melbourne,
Department of Paediatrics, Melbourne, Australia
Objectives: To compare rates of lower respiratory infection in pre-school children
with CF at two centres sharing similar approaches to treatment and use of
antimicrobial prophylaxis.
Methods: Bronchoalveolar lavage ﬂuids (n = 997) obtained from Melbourne-
(MEL) and Perth-based (PER) participants of the AREST CF early disease surveil-
lance program between January 2006 and September 2012 underwent diagnostic
microbiological examination.
Results: Both centres performed a similar number of tests each year (MEL 67.7,
PER 74.7; p = 0.46 paired t test). Although both study groups were of a similar
age (MEL 2.7 yrs, PER 3.3 yrs; p = 0.10), the Melbourne cohort had more males
(62% vs 44% PER; p = 0.001) and children homozygous for DF508 (60% vs 48%
PER; p = 0.002), but fewer patients identiﬁed by newborn screening (62% vs 90%
PER; p< 0.0001). The Melbourne cohort also had more culture-positive tests (54%
versus 28%, per year on average; p = 0.007), with a higher annual incidence of
A. fumigatus (9% MEL; 4% PER), E. coli (5% MEL; 1% PER), H. inﬂuenzae
(14% MEL; 5% PER), mixed oral ﬂora (66% MEL; 28% PER) and S. aureus (18%
MEL; 6% PER).
Conclusion: Reports of culture-positivity were below the national average for both
centres, which may reﬂect sampling methods that estimated incidence rather than
prevalence of lower respiratory infection. Differences in infection rates between
CF centres were identiﬁed and could be due to subtle differences in treatment
protocols, the analytical and reporting procedures used by the respective diagnostic
laboratories or genuine geographical differences in the incidence of early lower
respiratory infection.
129 Pseudomonas aeruginosa infecting lung-transplanted cystic
ﬁbrosis patients: A longitudinal study
P. Cocchi1, G. Taccetti2, N. Ravenni2, S. Bresci3, C. Braggion2, M. de Martino1,
S. Campana2. 1University of Florence, Department of Sciences for Women’s and
Children’s Health, Florence, Italy; 2Cystic Fibrosis Centre, Anna Meyer Children’s
Hospital, Florence, Italy; 3AOU Careggi, Florence, Italy
Objectives: Respiratory failure is the most important cause of death in cystic
ﬁbrosis (CF) patients, and lung transplantation (LT) is one treatment option for
end-stage pulmonary disease. Pseudomonas aeruginosa (PA) is the most common
bacterial pathogen responsible for CF pulmonary infection. The goal of this study
was to molecularly characterize PA strains responsible for pulmonary infection
before and after bilateral LT.
Methods: Fifty-two PA strains were collected over 13-years (1998–2010) from
respiratory samples of three CF patients, 42 strains before and 10 after LT.
Molecular typing was performed using BOX-PCR, data analysis using Gel Compare
II (Applied Maths, Belgium).
Results: Patient (PT) A provided 18 strains before and 4 strains after LT. Before
LT, two different clones were detected, replaced by a third clone maintained after
LT. PT B provided 9 strains before and 4 strains after LT: different genotypes were
detected, one clone replaced the others and was maintained after LT. PT C supplied
9 strains before LT and 4 after, all belonging to the same clone.
Conclusion: These data seem to describe that the single clone leading to the clinical
condition requiring LT persisted after surgery. In order to obtain a more detailed
and exhaustive picture, the number of both patients and strains before and after LT
should be increased. Multi Locus Sequence Typing could be performed to highlight
the presence of particular PA clones. These preliminary data suggest that more
studies are required.
130 Chronic infection with Pseudomonas aeruginosa in cystic
ﬁbrosis − A risk factor for nasal polyposis after lung
transplantation
D. Vital1, D. Holzmann1, A. Boehler2, M. Hofer2. 1University Hospital Zurich,
Dept. of Otorhinolaryngology, Head and Neck Surgery, Zurich, Switzerland;
2University Hospital − CF Adult Center, Dept. of Pulmonary Medicine, Zu¨rich,
Switzerland
Background: Nasal polyposis (NP) is common in cystic ﬁbrosis (CF) patients.
The prevalence of the CF phenotype with NP after lung transplantation (LTx) is
unknown. Risk factors for the development of NP after LTx are not well described.
Methods: CF patients with LTx at our centre between November 1992 and De-
cember 2009 were included. They were regularly investigated with nasal endoscopy
and aspiration of sinus secretions with microbiological evaluation. Patients with and
without development of NP were compared along the following parameters: gender,
age, dF508, diabetes, acute rejection, NP at LTx and microbiology of the sinuses
before and after LTx. A multivariate cox regression analysis was performed.
Results: The study included 94 patients; 21 were excluded due to incomplete
data. Thirty-ﬁve (48%) of the remaining 73 patients developed NP. Mean time
to diagnosis of NP was 4.2 (2.9−5.6) years after LTx. Prevalence of NP was 11%
after the ﬁrst year and 18%, 33% and 44% after the ﬁrst two, ﬁve and ten years,
respectively. Patients with post-transplant NP were younger, had NP before LTx
and were chronically infected with Pseudomonas aeruginosa (PA) in the nose.
Multivariate analysis demonstrated that chronic infection with PA was the only
signiﬁcant risk factor for the development of nasal polyps after lung transplantation
(HR 4.812, 95%CI 1.466–15.792, p = 0.01).
Conclusions: In contrast to pre-transplant patients, NP is more common after
LTx. Development of NP occurs throughout the whole observation time. Chronic
sinonasal PA infection seems to be the only signiﬁcant risk factor for NP after LTx.
